IBDEI03X ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1481,2)
 ;;=^56228
 ;;^UTILITY(U,$J,358.3,1482,0)
 ;;=453.1^^11^123^54
 ;;^UTILITY(U,$J,358.3,1482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1482,1,4,0)
 ;;=4^453.1
 ;;^UTILITY(U,$J,358.3,1482,1,5,0)
 ;;=5^Thrombophlebitis Migra
 ;;^UTILITY(U,$J,358.3,1482,2)
 ;;=^265511
 ;;^UTILITY(U,$J,358.3,1483,0)
 ;;=453.2^^11^123^49
 ;;^UTILITY(U,$J,358.3,1483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1483,1,4,0)
 ;;=4^453.2
 ;;^UTILITY(U,$J,358.3,1483,1,5,0)
 ;;=5^Thombus Vena Cava
 ;;^UTILITY(U,$J,358.3,1483,2)
 ;;=^269817
 ;;^UTILITY(U,$J,358.3,1484,0)
 ;;=453.3^^11^123^60
 ;;^UTILITY(U,$J,358.3,1484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1484,1,4,0)
 ;;=4^453.3
 ;;^UTILITY(U,$J,358.3,1484,1,5,0)
 ;;=5^Thrombus Renal Vein
 ;;^UTILITY(U,$J,358.3,1484,2)
 ;;=^269818
 ;;^UTILITY(U,$J,358.3,1485,0)
 ;;=459.2^^11^123^47
 ;;^UTILITY(U,$J,358.3,1485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1485,1,4,0)
 ;;=4^459.2
 ;;^UTILITY(U,$J,358.3,1485,1,5,0)
 ;;=5^Stricture Vein
 ;;^UTILITY(U,$J,358.3,1485,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,1486,0)
 ;;=459.81^^11^123^39
 ;;^UTILITY(U,$J,358.3,1486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1486,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,1486,1,5,0)
 ;;=5^Chronic Venous Insuf
 ;;^UTILITY(U,$J,358.3,1486,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,1487,0)
 ;;=451.11^^11^123^42
 ;;^UTILITY(U,$J,358.3,1487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1487,1,4,0)
 ;;=4^451.11
 ;;^UTILITY(U,$J,358.3,1487,1,5,0)
 ;;=5^Phleb/Throm Fem V Deep
 ;;^UTILITY(U,$J,358.3,1487,2)
 ;;=^269811
 ;;^UTILITY(U,$J,358.3,1488,0)
 ;;=438.89^^11^123^38
 ;;^UTILITY(U,$J,358.3,1488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1488,1,4,0)
 ;;=4^438.89
 ;;^UTILITY(U,$J,358.3,1488,1,5,0)
 ;;=5^CVA, Late Effect
 ;;^UTILITY(U,$J,358.3,1488,2)
 ;;=^317924
 ;;^UTILITY(U,$J,358.3,1489,0)
 ;;=453.89^^11^123^59
 ;;^UTILITY(U,$J,358.3,1489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1489,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,1489,1,5,0)
 ;;=5^Thrombus Other Vein
 ;;^UTILITY(U,$J,358.3,1489,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,1490,0)
 ;;=444.01^^11^123^45
 ;;^UTILITY(U,$J,358.3,1490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1490,1,4,0)
 ;;=4^444.01
 ;;^UTILITY(U,$J,358.3,1490,1,5,0)
 ;;=5^Saddle Embolus-Abd Aorta
 ;;^UTILITY(U,$J,358.3,1490,2)
 ;;=^340522
 ;;^UTILITY(U,$J,358.3,1491,0)
 ;;=444.09^^11^123^16
 ;;^UTILITY(U,$J,358.3,1491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1491,1,4,0)
 ;;=4^444.09
 ;;^UTILITY(U,$J,358.3,1491,1,5,0)
 ;;=5^Art Emb/Thrm Abd Aorta NEC
 ;;^UTILITY(U,$J,358.3,1491,2)
 ;;=^340523
 ;;^UTILITY(U,$J,358.3,1492,0)
 ;;=078.5^^11^124^1
 ;;^UTILITY(U,$J,358.3,1492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1492,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,1492,1,5,0)
 ;;=5^CMV Infection
 ;;^UTILITY(U,$J,358.3,1492,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,1493,0)
 ;;=420.90^^11^124^8
 ;;^UTILITY(U,$J,358.3,1493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1493,1,4,0)
 ;;=4^420.90
 ;;^UTILITY(U,$J,358.3,1493,1,5,0)
 ;;=5^Pericarditis, Acute
 ;;^UTILITY(U,$J,358.3,1493,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,1494,0)
 ;;=420.91^^11^124^7
 ;;^UTILITY(U,$J,358.3,1494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1494,1,4,0)
 ;;=4^420.91
 ;;^UTILITY(U,$J,358.3,1494,1,5,0)
 ;;=5^Pericardit, Acute Viral
 ;;^UTILITY(U,$J,358.3,1494,2)
 ;;=^269695
 ;;^UTILITY(U,$J,358.3,1495,0)
 ;;=421.0^^11^124^5
 ;;^UTILITY(U,$J,358.3,1495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1495,1,4,0)
 ;;=4^421.0
 ;;^UTILITY(U,$J,358.3,1495,1,5,0)
 ;;=5^Endocarditis, Acute/Sub Bact
